-
Trevi Therapeutics' (TRVI) Buy Rating Reaffirmed at B. Riley
来源: Buzz FX / 07 10月 2024 11:51:10 America/New_York
Trevi Therapeutics' (TRVI) Buy Rating Reaffirmed at B. Riley Written by MarketBeat October 7, 2024 Share Link copied to clipboard. Trevi Therapeutics ( NASDAQ:TRVI - Get Free Report ) 's stock had its "buy" rating reaffirmed by analysts at
Read more...